PD‐L1+ tumor cells can interact with PD1+ antigen‐specific CD8+ T cells and decrease their effector functions by interfering with the signaling cascade downstream of PD1 (Pauken et al, 2021). The gene discussed is CD8A; the disease is neoplasm.